Merck (NYSE:MRK) has ended acquisition talks with oncology-focused Revolution Medicines. The discussions centered on a ...

Merck & Company Inc (NYSE:MRK) has reportedly ended discussions to acquire Revolution Medicines Inc (NASDAQ:RVMD) after the two sides failed to agree on valuation, according to the Wall Street Journal ...

Merck (MRK) closed the most recent trading day at $108.34, moving +1.35% from the previous trading session. The stock ...

RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based pharmaceutical giant has completed its $9.2 billion acquisition of Cidara ...

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Merck has appointed Benjamin Hein as a new member of its executive board and CEO of the company’s Electronics Business. The company announced on ...

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent cliff. The pharmaceutical leader has made an agreement to acquire the COPD ...

Technology is changing the way pharmaceutical companies discover and develop new drugs. For Matt Studney, who joined Merck as a chemical engineer, technology changed the course of his career. In 2017, ...

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to ...